The Senate Health, Education, Labor & Pensions Committee today held a hearing on telehealth lessons from the COVID-19 pandemic.

Witnesses from the University of Virginia’s Center for Telehealth, American Telemedicine Association, Project ECHO and BlueCross BlueShield of Tennessee shared how certain legislative and regulatory changes to expand access to virtual care during the public health emergency are benefiting patients and could in the future if continued. Members of the committee also shared specific examples of increased utilization in their local hospitals.

In opening remarks, committee Chairman Lamar Alexander, R-Tenn., said the federal government should permanently extend policy changes that nearly doubled the number of Medicare-reimbursable telehealth services and reimburse clinicians for telehealth services provided wherever the patient is located, and consider making 29 other COVID-19 policy changes permanent.

A bipartisan group of 30 senators this week urged congressional leaders to make permanent provisions included in previous COVID-19 legislation to expand access to telehealth services for Medicare beneficiaries.  

AHA has identified legislative and regulatory actions needed to maintain or extend these and other telehealth flexibilities implemented during the emergency. The actions address provider/patient location; providers and facilities eligible to deliver telehealth services; types of services; billing, payment and coverage for telehealth.

Related News Articles

Headline
The departments of Health and Human Services and Defense yesterday announced an agreement to purchase at least 105 million doses of a Pfizer omicron-…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and Food and Drug Administration this week…
#HealthCareInnovation Thursday Blog
Recently, nearly 1,000 health care leaders and changemakers convened at Aspen Ideas: Health, part of the Aspen Institute’s Aspen Ideas Festival, to explore…
Headline
The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody…
Headline
The Centers for Disease Control and Prevention last night endorsed Moderna’s COVID-19 vaccine for children aged 6-17, as its advisory committee…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today unanimously recommended Moderna’s COVID-19 vaccine for…